Chloroquine potentiation of thioridazine effects in rats and drug-resistant schizophrenic patients: a preliminary report.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000378:metabolism; D002738:Chloroquine / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004351:Drug Resistance; D004357:Drug Synergism; D006801:Humans; D008297:Male; D051381:Rats; D012559:Schizophrenia / Q000188:drug therapy*; D013239:Stereotyped Behavior / Q000187:drug effects; D013881:Thioridazine / Q000378:metabolism / Q000627:therapeutic use*; D013997:Time Factors
D002738:Chloroquine; D000661:Amphetamine; D013881:Thioridazine